Follow
Jack Roth
Jack Roth
Professor of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Somatic mutations affect key pathways in lung adenocarcinoma
L Ding, G Getz, DA Wheeler, ER Mardis, MD McLellan, K Cibulskis, ...
Nature 455 (7216), 1069-1075, 2008
30932008
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu, L Lin, T Takahashi, M Nomura, M Suzuki, II Wistuba, ...
Journal of the National Cancer Institute 97 (5), 339-346, 2005
29192005
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
DP Kelsen, R Ginsberg, TF Pajak, DG Sheahan, L Gunderson, J Mortimer, ...
New England Journal of Medicine 339 (27), 1979-1984, 1998
16701998
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ...
The lancet oncology 16 (6), 630-637, 2015
15562015
BRAF and RAS mutations in human lung cancer and melanoma
MS Brose, P Volpe, M Feldman, M Kumar, I Rishi, R Gerrero, E Einhorn, ...
Cancer research 62 (23), 6997-7000, 2002
14822002
A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
JA Roth, F Fossella, R Komaki, MB Ryan, JB Putnam Jr, JS Lee, ...
JNCI: Journal of the National Cancer Institute 86 (9), 673-680, 1994
14051994
Characterizing the cancer genome in lung adenocarcinoma
BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ...
Nature 450 (7171), 893-898, 2007
12732007
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
LB Owen-Schaub, W Zhang, JC Cusack, LS Angelo, SM Santee, ...
Molecular and cellular biology, 1995
10951995
Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.
JA Roth, D Nguyen, DD Lawrence, BL Kemp, CH Carrasco, DZ Ferson, ...
Nature medicine 2 (9), 985-991, 1996
10101996
Gene therapy for cancer: what have we done and where are we going?
JA Roth, RJ Cristiano
Journal of the National Cancer Institute 89 (1), 21-39, 1997
9231997
Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Type p53 Gene
T Fujiwara, EA Grimm, T Mukhopadhyay, WW Zhang, LB Owen-Schaub, ...
Cancer Research 54 (9), 2287-2291, 1994
6871994
Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
SG Swisher, JA Roth, J Nemunaitis, DD Lawrence, BL Kemp, ...
Journal of the National Cancer Institute 91 (9), 763-771, 1999
6521999
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal …
DP Kelsen, KA Winter, LL Gunderson, J Mortimer, NC Estes, DG Haller, ...
Journal of Clinical Oncology 25 (24), 3719-3725, 2007
6212007
Focus on lung cancer
JD Minna, JA Roth, AF Gazdar
Cancer cell 1 (1), 49-52, 2002
6112002
Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung …
JA Roth, EN Atkinson, F Fossella, R Komaki, MB Ryan, JB Putnam Jr, ...
Lung cancer 21 (1), 1-6, 1998
5951998
LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON. 3. EVIDENCE THAT IL-2 IS SUFFICIENT FOR DIRECT ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES INTO LYMPHOKINE-ACTIVATED KILLER CELLS
EA Grimm, RJ Robb, JA Roth, LM Neckers, LB Lachman, DJ Wilson, ...
JOURNAL OF EXPERIMENTAL MEDICINE 158 (4), 1356-1361, 1983
538*1983
Survival in early-stage non-small cell lung cancer
JC Nesbitt, JB Putnam Jr, GL Walsh, JA Roth, CF Mountain
The Annals of thoracic surgery 60 (2), 466-472, 1995
5191995
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
LR Chirieac, SG Swisher, JA Ajani, RR Komaki, AM Correa, JS Morris, ...
Cancer 103 (7), 1347-1355, 2005
5112005
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao, SM Groves, S Heeke, BY Nabet, ...
Cancer cell 39 (3), 346-360. e7, 2021
5092021
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
GL Clayman, AK El-Naggar, SM Lippman, YC Henderson, M Frederick, ...
Journal of Clinical Oncology 16 (6), 2221-2232, 1998
4981998
The system can't perform the operation now. Try again later.
Articles 1–20